Showing posts with label respiratory illness. Show all posts
Showing posts with label respiratory illness. Show all posts

Thursday, June 20, 2024

Cannabis users are at increased risk of severe Covid, study finds

Intensive care (Photo by Matt Miller, Washington University)
Kentucky Health News

Use of cannabis, commonly called marijuana, is linked to increased risk of serious illness for those with Covid-19. So says a study in the American Medical Association journal JAMA Network Open by researchers at the Washington University in St. Louis.

“There’s this sense among the public that cannabis is safe to use, that it’s not as bad for your health as smoking or drinking, that it may even be good for you,” Dr. Li-Shiun Chen, a professor of psychiatry and senior author of the study, said in a university news release.

“I think that’s because there hasn’t been as much research on the health effects of cannabis as compared to tobacco or alcohol. What we found is that cannabis use is not harmless in the context of Covid-19. People who reported . . . current cannabis use, at any frequency, were more likely to require hospitalization and intensive care than those who did not use cannabis.”

Cannabis use differed from tobacco smoking in one key measurement: survival. While smokers were significantly more likely to die of Covid-19 than nonsmokers — a finding that fits with numerous other studies — the same was not true of cannabis users, the news release said.

“The independent effect of cannabis is similar to the independent effect of tobacco regarding the risk of hospitalization and intensive care,” Chen said. “For the risk of death, tobacco risk is clear but more evidence is needed for cannabis.”

The researchers analyzed the health records of 72,501 people seen for Covid-19 at BJC HealthCare hospitals and clinics in Missouri and Illinois during the first two years of the pandemic. They "found that people who reported using any form of cannabis at least once in the year before developing Covid-19 were significantly more likely to need hospitalization and intensive care than were people with no such history," the release says. "This elevated risk of severe illness was on par with that from smoking."

The records contained demographic characteristics; medical conditions; use of substances including tobacco, alcohol, cannabis and vaping; and hospitalization, admittance to an intensive-care unit, and survival.

"Covid-19 patients who reported that they had used cannabis in the previous year were 80% more likely to be hospitalized and 27% more likely to be admitted to the ICU than patients who had not used cannabis, after taking into account tobacco smoking, vaccination, other health conditions, date of diagnosis, and demographic factors," the release says. "For comparison, tobacco smokers with Covid-19 were 72% more likely to be hospitalized and 22% more likely to require intensive care than were nonsmokers, after adjusting for other factors. These results contradict some other research suggesting that cannabis may help the body fight off viral diseases such as Covid-19.

Chen said, “Most of the evidence suggesting that cannabis is good for you comes from studies in cells or animals. The advantage of our study is that it is in people and uses real-world health-care data collected across multiple sites over an extended time period. All the outcomes were verified: hospitalization, ICU stay, death. Using this data set, we were able to confirm the well-established effects of smoking, which suggests that the data are reliable.”

The release says, "The study was not designed to answer the question of why cannabis use might make Covid-19 worse. One possibility is that inhaling marijuana smoke injures delicate lung tissue and makes it more vulnerable to infection, in much the same way that tobacco smoke causes lung damage that puts people at risk of pneumonia, the researchers said. That isn’t to say that taking edibles would be safer than smoking joints. It is also possible that cannabis, which is known to suppress the immune system, undermines the body’s ability to fight off viral infections no matter how it is consumed, the researchers noted."

“We just don’t know whether edibles are safer,” said first author Nicholas Griffith, MD, a medical resident at Washington University, who was a medical student therev when he led the study. “People were asked a yes-or-no question: ‘Have you used cannabis in the past year?’ That gave us enough information to establish that if you use cannabis, your health-care journey will be different, but we can’t know how much cannabis you have to use, or whether it makes a difference whether you smoke it or eat edibles. Those are questions we’d really like the answers to. I hope this study opens the door to more research on the health effects of cannabis.”

Friday, June 14, 2024

Whooping cough cases keep rising in Lexington and statewide; anyone with cold-like symptoms lasting 2 weeks should get tested

By Melissa Patrick
Kentucky Health News

Fayette County continues to experience a whooping cough outbreak, part of a statewide year-to-year increase in cases of the disease that is most serious in infants, young children and those with chronic diseases.

"Lexington has more pertussis, or whooping cough, cases in the last six weeks than the previous five years combined," Kevin Hall, communications officer for the Lexington-Fayette County Health Department, said in an email. "Fayette County is now up to 27 confirmed cases reported since April 26 . . .  compared to 16 total the previous five years."

Statewide, 25 of 120 counties have reported cases, and the total (76) has almost reached last year's total (84) with more than half of the year remaining.

2024 pertussis cases by county
(Data from state Dept. for Public Health)
Whooping cough, known medically as pertussis, is a highly contagious respiratory illness spread by coughing and sneezing.  Infected people can spread the disease from the start of symptoms and at least two weeks after coughing begins. 

Early symptoms of whooping cough look like a common cold, including runny nose, sneezing, mild cough and low-grade fever. After one to two weeks, long coughing spells develop, which often occur in explosive bursts, sometimes ending with a high-pitched whoop and vomiting. This can go on for up to 10 weeks or more, according to the Centers for Disease Control and Prevention.

The best way to prevent whooping cough is through vaccination. The childhood vaccine is called DTaP. Infants should receive a series of DTaP immunizations at 2, 4, and 6 months, with boosters at 15-18 months and 4-6 years. Children should then get a single dose of the booster, called Tdap, at 11 or 12. Boosters are required every 10 years to maintain efficacy.

"Anyone with cold-like symptoms lasting a week or two should ask their provider to be tested for pertussis," said Hall. "A cough isn’t always present, and the violent cough takes a few weeks before it appears, if it happens at all."

So far in 2024, 76 confirmed cases of pertussis have been reported in Kentucky. That's up from 46 confirmed cases that were reported by the state to Kentucky Health News in mid-May. The state had 35 cases in 2022 and 84 in 2023.

Last May, State Epidemiologist Kathleen Winter said at an immunization summit that the U.S. has a spike in pertussis about every five years. She said there was a "major epidemic" in 2012 and "We are well positioned to have another one." 

Asked about this, Brice Mitchell, a spokesman for the state Department for Public Health, said in an email dated May 24 that while cases of pertussis tend to peak every three to five years, this pattern was disrupted during the Covid-19 pandemic. 

"In recent years, pertussis incidence has remained low in Kentucky. (35 cases in 2022 and 84 cases in 2023) The last major peak occurred in 2016-2017 when 463 and 449 cases were reported, respectively," he said. "There is no clear indication that Kentucky is currently headed into an elevated incidence year for pertussis, however the Kentucky Department for Public Health continues to work with local health departments to identify cases and closely monitor trends." 

Thursday, June 6, 2024

Kentucky is seeing an 'unusually high uptick' in pertussis, known as whooping cough; Lexington outbreak grows to 24 cases

Kentucky doctors and the state Department for Public Health "are seeing an unusually high uptick in whooping cough," or pertussis, Louisville's WDRB reports. "Immunity for vaccination or natural infections wanes over time, so people who are fully vaccinated can still get whooping cough. Doctors said the vaccine lessens the severity and will likely keep someone out of the hospital."

Kentucky had 84 confirmed cases of pertussis in 2023, and 66 confirmed so far in 2024, said Brice Mitchell, spokesman for the department. That works out to just under two cases a week last year, and just under three cases a week so far this year. 

Seven more cases of pertussis were confirmed in Lexington last week, bringing the total to 21 since April 26. The Lexington-Fayette County Health Department declared a pertussis outbreak on May 20. UPDATE, June 9: The department confirmed three more cases, bringing the total to 24.

Most of Kentucky's cases have been in school-age children, but some been in infants and adults, WDRB reports.

"It's not unusual to actually see whooping cough; however, the numbers that are being seen, that is definitely unusual, " Dr. Mark Burns of the University of Louisville told WDRB. "It's usually not that prevalent as it is right now."

The state is part of a spotty national trend. Clusters of pertussing cases have also been reported in Oregon and wetsren Pennsylvania. Through May, about 5,000 cases had been reported in the U.S., more than double the number for the same five months in 2022.

"Rates of whooping cough, like those of some other infectious diseases, declined soon after the start of the pandemic, as people wore masks and practiced social distancing, precautions that many have ceased," The Washington Post reports, quoting experts. "But during the early months of the pandemic, when people feared being exposed to the coronavirus in a doctor’s office, some children may have missed vaccination appointments, leaving them vulnerable to future infections."

C. Buddy Creech, director of the Vanderbilt University Vaccine Research Program and a pediatric infectious-disease researcher for 20 years, told the Post, “This is still a terrible, terrible disease, one we’d do well to protect against.”

The Centers for Disease Control and Prevention says pertussis cases are returning to “pre-pandemic patterns,” more than 10,000 cases a year. The Post reports, "From January 2023 through May 25, 2024, whooping cough caused 15 deaths in the United States, though the CDC declined to say how many of those deaths occurred this year," indicating that the number is less than 5.

"England has also reported a substantial increase in whooping cough cases in the first three months of 2024, including the deaths of five infants," the Post reports. "Although the disease is best known for its toll on babies, the infection can cause serious illness in people older than 65, including rib fractures and significant pneumonia, Creech said."

Friday, April 5, 2024

Respiratory-virus activity ticks up a bit, but hospital admissions fall; flu remains driver for respiratory admissions, ER visits in Ky.

State Department for Public Health graphs, adapted by Kentucky Health News

By Melissa Patrick
Kentucky Health News

The state Department for Public Health says respiratory virus activity ticked up a bit in Kentucky in the last week of March, but remained at a relatively low level, while hospitalizations for respiratory disease declined but remained at a level that the department considers moderate. 

In the week ended March 30, emergency-room visits for influenza, Covid-19 and respiratory syncytial virus (RSV) increased almost 5% to 1,796. Of those, 1,508 were for the flu. 

But in that same week, hospital admissions for the diseases dropped 19%, to 233.  Of those, 135 were for flu, 85 were for Covid-19 and 13 were for RSV. 

In the week ended March 30, every Kentucky county had a low rate of Covid-19 hospital admissions, considered to be less than 10 admissions per 100,000 people by the Centers for Disease Control and Prevention. 

The state reported 1,431 laboratory-confirmed cases of the flu in the week ended March 30, showing the first uptick in confirmed flu cases since mid-February. The state reported 857 lab-confirmed cases of Covid-19, which have declined for seven weeks in a row.  

The Kentucky Respiratory Disease Dashboard is now reporting Kentucky monthly death information for all Kentuckians since October 2023 as well as a separate category for those 65 and older during the 2023-24 respiratory season. 

The dashboard shows that since the flu season began in October,  there have been a total of 524 deaths attributed to Covid-19, with 447 of them in people 65 and older. One Covid-19 victim and one flu victim were children. There have been 121 flu-related deaths, with 74 in people 65 and older. Ten deaths have been attributed to co-infection, with two of in people 65 and older.

Monday, April 1, 2024

Paxlovid is effective against Covid-19, but many people eligible for it are not getting it; it's free to Medicare and Medicaid beneficiaries

Getty Images
By Dr. Nicholas Van Sickels
University of Kentucky

A safe and effective medication designed to prevent mild to moderate Covid-19 infections from becoming more dangerous has been available for almost two years. But recent studies have shown many patients eligible for the drug – Paxlovid – haven’t been prescribed it.

In a clinical trial, the orally taken medication reduced the risk of hospitalization and death by 86 percent. Paxlovid was fully approved by the Food and Drug Administration in May 2023 but has been available through an emergency-use authorization since 2022.

A pre-print study of over a million Covid-19 patients found that less than 10% of eligible patients were prescribed Paxlovid, also known as nirmatrelvir-ritonavir. The reasons behind the treatment’s slow uptake could include confusion over who’s eligible or even unfamiliarity with the drug.

How does it work? The antiviral drug works to stop the replication of the virus which causes Covid-19 at the cellular level. It comes as a dose pack; two of the pills are the active medicine, nirmatrelvir, and one is a “booster” medicine, ritonavir, which helps the nirmatrelvir maintain effective levels in the bloodstream.

Paxlovid is most effective when taken within five days of developing symptoms.

Who’s eligible? The treatment is designed for high-risk patients who have a mild or moderate case of Covid-19 but hope to avoid more severe consequences. You might be considered high-risk if you’re:
  • Over 50
  • Not up to date on COVID vaccinations
  • Immunocompromised
  • Pregnant
  • Have any other medical conditions like diabetes, hypertension or asthma
A full list of medical conditions that may leave you at high-risk for a severe case of COVID-19 are listed on the CDC’s website here.

When should I ask my doctor about Paxlovid? If you are at high-risk for complications from Covid-19, it’s best not to wait before asking your doctor about Paxlovid. The treatment should be taken within five days of the onset of symptoms.

A study from the University of Hong Kong, which analyzed data from over 87,000 patients who took nirmatrelvir-ritonavir, found that earlier treatment within that five-day window leads to better outcomes.

The treatment will be free for Medicare or Medicaid beneficiaries through the end of 2024 via the U.S. government’s Patient Assistance Program. Those with private insurance can enroll in the Paxcess program to help lower out-of-pocket costs.

When you ask your health care provider about Paxlovid, make sure to update them on all other medications you are taking. While most medications are generally safe to take with Paxlovid, there are some which need dose adjustments or should be held during and for a short while after treatment. On very rare occasions, treatments other than Paxlovid are needed for people at high-risk for complications from Covid-19 who take certain medications.

How can I best protect myself from Covid-19? Improvements in how Covid-19 is prevented and treated have led to a relative relaxation in guidance on how to avoid the virus. In early March, the Centers for Disease Control and Prevention began to group its Covid-19 guidelines with other diseases caused by respiratory viruses such as flu and respiratory syncytial virus.

The basic guidelines around avoiding respiratory viruses include:
  • Staying up to date on your immunizations
  • Practicing good hygiene like proper handwashing or covering coughs
  • Access cleaner air by opening windows or gathering outdoors

If you get sick with a respiratory virus, it’s best to stay home and away from others.

Nicholas Van Sickels, M.D., is director of infection prevention and control at UK HealthCare.

Sunday, March 24, 2024

Emergency-department visits and hospitalizations for respiratory illness keep dropping; at 'moderate' level for first time since fall

State Department for Public Health graphs, adapted by Kentucky Health News

By Melissa Patrick

Kentucky Health News

For the first time since December, the state Department for Public Health says both respiratory-virus activity and hospital admissions related to respiratory disease are moderate and declining in Kentucky. 

In the week ended March 16, emergency-department visits for influenza, Covid-19 and respiratory syncytial virus (RSV) dropped 30%, to 1,936. Of those visits, 1,555 were for flu. 

Hospital admissions for the diseases dropped 38%, to 272. Of those, 141 hospital admissions were for flu, 111 for Covid-19 and 20 were for RSV. 

In that same week, eight Kentucky counties had Covid-19 hospital admission rates between 10 and 19.9 admissions per 100,000 population, which the the Centers for Disease Control and Prevention considers to be a "medium" rate. Those counties were Clay, Elliott, Knox, Laurel, Menifee, Morgan, Rowan and Whitley. 

The state reported 1,761 laboratory-confirmed cases of the flu in the week ended March 16 and 1,121 lab-confirmed cases of Covid-19. These numbers have dropped for five weeks in a row. 

Since the flu season began in October, the state has recorded 439 Covid-19 deaths, 110 flu deaths and two co-infection deaths. One Covid-19 victim and one flu victim were children. 

Sunday, March 17, 2024

ED visits, hospitalizations for respiratory disease decline in state

State Department for Public Health graphs, adapted by Kentucky Health News
By Melissa Patrick
Kentucky Health News

Kentucky's influenza levels remain elevated, but are declining, and hospitalizations for overall respiratory illness are moderate and declining, according to the state Department for Public Health.

In the week ended March 9, emergency-department visits for the three main respiratory diseases showed a 16% drop in visits for Covid-19, flu and RSV, to 2,734. Of those, 79% of the visits were attributed to the flu. 

Hospital admissions for the diseases dropped 28% in the week ended March 9, to 387. Of those admissions, 216 were for the flu, 154 were for Covid-19 and 17 were for RSV (respiratory syncitial virus).

In the week ended March 9, 10 Kentucky counties had a Covid-19 hospital admission rate between 10 and 19.9 admissions per 100,000 people, a rate that is considered "medium" by the Centers for Disease Control and Prevention. 

Those counties were McCracken, Marshall, Lyon, Livingston, Hickman, Graves, Crittenden, Carlisle and Ballard, in West Kentucky, and Letcher, on Kentucky's southeastern border.

The state reported 2,762 laboratory-confirmed cases of the flu in the week ended March 9 and 1,605 lab-confirmed cases of Covid-19. Both of these numbers have dropped for four weeks in a row. 

Since the flu season began in October, the state has recorded 439 Covid-19 deaths, 110 flu deaths and two co-infection deaths, both reported in recent weeks. One Covid-19 victim and one flu victim were children.

Sunday, March 3, 2024

Flu shots limit infection rates, which are still elevated in Kentucky

State health department graphs, adapted by Kentucky Health News
By Melissa Patrick
Kentucky Health News

The Kentucky Department for Public Health still considers hospitalizations for respiratory illnesses high and says flu activity remains elevated. 

Health officials say the best way to protect yourself from these viruses is to stay up to date with your vaccines. 

The Centers for Disease Control and Prevention recommends that everyone 6 months old and older get the annual flu vaccine and updated Covid-19 vaccines, especially children younger than 5 or anyone at high risk for complications.

Vaccines for respiratory syncitial virus are recommended for some infants and young children, pregnant women and adults 60 and older. At some places and times, there has been a shortage of these vaccines. 

This year's "flu vaccines have worked, substantially reducing the risk of flu-related medical visits and hospitalizations across all age groups, with some estimates higher than have been previously observed, even during well-matched seasons," said a CDC report released on Feb. 29.

"Specifically, flu vaccination has reduced the risk of flu medical visits by about two-thirds and flu-related hospitalization by about half for vaccinated children and flu medical visits by half and hospitalization by about 40% for vaccinated adults."

Even though flu season usually peaks around January, it lasts until May. Health experts say that if there is any flu activity occurring, it's not too late to get vaccinated.

What the numbers say

Emergency-department visits for respiratory illness in Kentucky have stayed about the same for the last two weeks, with 3,607 visits reported in the week ended Feb. 24.

Hospitalizations for respiratory disease in that week stayed about the same as the week prior, with 491 530 hospitalizations reported in the week ended Feb. 24. 

Kentucky had 20 counties with Covid-19 hospitalizations between 10 and 19.9 hospitalizations per 100,000 people, a rate that the  CDC considers "medium." 

Those counties are Adair, Green, Russell, Taylor, Clinton, Cumberland, Lewis, Elliott, Menifee, Morgan, Rowan, Barren, Hart, Metcalfe, Monroe, Bath, Montgomery, Floyd, Johnson and Magoffin. 

Overall, there was little change in the three respiratory viruses tracked by the state health department: Covid-19, influenza and RSV, with flu continuing to drive ED visits and hospital admissions. 

The state reported 3,857 laboratory confirmed cases of the flu in the week ended Feb. 24 and 2,246 laboratory confirmed cases of Covid-19. This reflected a slight drop in flu cases and a nearly 9% drop in Covid cases.

Among children, ED visits for respiratory disease increased 12% in children four and younger, to 671, compared to the prior week, and hospitalizations for children 5 to 17 increased 50%, to 18. The increase in ED visits for younger children was driven by the flu, and hospitalizations for the older children were driven by an increase in  both flu and Covid-19.

Since the respiratory-illness season began the first week in October, 384 Kentuckians have died from Covid-19, and 51 from flu, according to the health department. One Covid-19 victim and one flu victim have been children. 

Friday, March 1, 2024

CDC shortens Covid-19 isolation advice to match other viruses

Centers for Disease Control and Prevention photo
By Melissa Patrick
Kentucky Health News

The Centers for Disease Control and Prevention has updated guidance for how long people need to isolate when they get Covid-19, to match the guidance for dealing with other viruses. 

"While every respiratory virus does not act the same, adopting a unified approach to limiting disease spread makes recommendations easier to follow and thus more likely to be adopted and does not rely on individuals to test for illness, a practice that data indicates is uneven," the CDC said in a news release.

As of March 1, people who test positive for Covid-19 no longer need to stay isolated for five days, but instead can return to their regular activities if their symptoms are mild and improving and they have been fever-free for 24 hours without the use of a fever-reducing medication. 

"This advice is similar to what has been recommended for flu for decades and will help reduce the spread of Covid-19 and other respiratory viruses during the most contagious period after infection," says a separate advisory. 

Once people get back to their normal activities, the CDC acknowledges that some people may still be contagious. Because of this, it calls on people to take additional precautions for the next five days, such as gathering outdoors when possible, practicing good hygiene, keeping a distance from others and wearing a well-fitting mask. 

The CDC says it is making updates to the recommendations now because the U.S. is seeing far fewer hospitalizations and deaths associated with Covid-19 and because there are more tools than ever to combat flu, Covid and respiratory syncitial virus (RSV). 

“Today’s announcement reflects the progress we have made in protecting against severe illness from Covid-19,” Dr. Mandy Cohen, the CDC director, said in the release. “However, we still must use the commonsense solutions we know work to protect ourselves and others from serious illness from respiratory viruses—this includes vaccination, treatment, and staying home when we get sick.”

This updated guidance is intended for community settings only. There are no changes to guidelines for nursing homes and health-care facilities.

Saturday, February 24, 2024

Emergency-department visits and hospitalizations for respiratory illness in Kentucky were down slightly from last week's uptick

State Department for Public Health graphs, adapted by Kentucky Health News

By Melissa Patrick
Kentucky Health News

While still considered high, Kentucky hospitalizations for respiratory disease dropped 15% in the week ending Feb. 17 after increasing in the previous week. 

The state Department for Public Health's weekly respiratory-illness report says 454 Kentuckians were hospitalized during the week, with big drops in all three respiratory viruses the state tracks -- flu, Covid-19 and respiratory syncytial virus (RSV). 

However, even with an 11% drop in Covid-19 hospitalizations, 15 Kentucky counties had a Covid-19 hospitalization rate between 10 and 10.9 per 100,000 people, considered an elevated or medium rate by the Centers for Disease Control and Prevention, and four Kentucky counties continued to have high rates of Covid-19 hospitalizations: Elliott, Menifee, Morgan and Rowan, all with rates of 21.2 per 100,000. 

The counties with medium rates of Covid-19 hospital admissions were Pike and Letcher, in far eastern Kentucky; Daviess, McLean, Ohio and Hancock, in western Kentucky; and Ballard, Carlisle, Crittenden, Graves, Hickman, Livingston, Lyon, Marshall and McCracken, in far west Kentucky.

Emergency-department visits for respiratory illness in Kentucky dropped 4% in the week ended Feb. 17, to 3,481. The biggest drop was among patients with RSV (down 27%), followed by a drop in Covid-19 visits (down 12%). 

ED visits by 5- to 17-year-olds leveled off, largely because flu visits, while still high, leveled off. During the week, 880 children in this group visited EDs for flu. 

Both flu and Covid-19 saw slight drops in laboratory-confirmed cases in the week ended Feb. 17. Lab-confirmed flu cases dropped to 3,860 and lab-confirmed Covid-19 cases dropped to 2,430. 

Since the respiratory-illness season began the first week in October, 361 Kentuckians have died from Covid-19, and 51 from the flu, according to the health department. One Covid-19 victim and one flu victim have been children. 

It's important to remember that flu and Covid-19 related deaths are reported in the week they happened, which can create an uptick in these numbers on any given week even though the deaths did not happen in that week. 

For example, this week's report shows an increase of 34 Covid-19 deaths and an increase of 23 flu deaths over the last report even though no new deaths were reported in the week ended Feb. 17.

Sunday, February 18, 2024

Respiratory illness in Ky. resurged in the week ended Feb. 10, with 5-to-17-year-olds having an 84% jump in ED visits for the flu

State Department for Public Health graphs, adapted by Kentucky Health News
By Melissa Patrick
Kentucky Health News

After weeks of overall decline, three major respiratory illnesses increased in Kentucky during the week ended Feb. 10, with children between the ages of 5 and 17 getting hit hard by influenza.  

The Kentucky Department for Public Health's weekly report says flu and Covid-19 activity is elevated and increasing and hospitalizations for respiratory illnesses are considered high.  

Emergency-department visits for the three respiratory viruses tracked by the state -- flu, Covid-19 and respiratory syncytial virus (RSV) -- increased nearly 16% in the week ended Feb. 10, to 3,583.  

This increase was driven by a 16% increase in visits for flu, to 2,745, and a 26% increase in Covid-19 visits, to 740. RSV visits dropped 26%, to 98. 

In the same week, Kentucky hospital admissions for the respiratory diseases increased 6% from the previous week, to 509. Flu was the only one of the tracked viruses to see an increase in hospital admissions in the week ended Feb. 10, with a 17% increase to 288. Covid-19 and RSV admissions had slight drops.  

Four northeastern Kentucky counties had high rates of Covid-19 hospital admissions in the week, according to the Centers for Disease Control and Prevention, which considers high to be 20 or more admissions per 100,000 residents. Rowan, Morgan, Menifee and Elliott counties had 27 Covid-19 admissions per 100,000. 

Ten Kentucky counties had admission rates between 10 and 19.9 Covid-19 admissions per 100,000, a rate the CDC considers "medium." They were Pike County, in far Eastern Kentucky, and McCracken, Marshall, Lyon, Livingston, Hickman, Graves, Crittenden, Carlisle, and Ballard counties, in far Western Kentucky. 

Children between the ages of 5-17 saw an 84% jump in emergency-department visits for respiratory illness in the week ended Feb. 10, to 970. This was driven by flu-related visits, which were up 82% over the previous week, to 876. Hospital visits for this age group dropped to 15 in that week, down from 22 the prior week. 

In the week ended Feb. 10, the state reported 3,912 laboratory-confirmed cases of the flu, up 17% from the prior week. It reported 2,459 laboratory-confirmed cases of Covid-19, up 16% from the week prior. 

Since the respiratory-illness season began the first week in October, 327 Kentuckians have died from Covid-19, and 28 from the flu, the health department says. One Covid-19 victim and one flu victim have been children.

Saturday, February 17, 2024

Bill to raise annual purchase limit on pseudoephedrine (Sudafed) and remove package-per-transaction limit moves to Senate

By Melissa Patrick
Kentucky Health News

A bill to raise the annual purchase limit on pseudoephedrine, the active ingredient in the decongestant Sudafed, has passed the state House and is in the Senate for consideration.  

Rep. Robert Duvall
"This is a pro-consumer, reasonable accommodation for Kentucky families seeking to find relief from congestion associated with the common cold and allergies," said the bill's sponsor, Rep. Robert Duvall, R-Bowling Green. "It simply increases access to affordable health care."

House Bill 386 passed the House Feb. 12 on a vote of 80-9, with Republican Rep. Danny Bentley, a pharmacist from Russell (Greenup County), abstaining.

This bill is in response to Kentucky and federal laws passed in 2005 that restrict the sale of products with pseudoephedrine, which at the time was a key ingredient for methamphetamine production. Kentucky strengthened this law in 2012. Since the passage of these laws, most meth in the U.S. comes from Mexico, according to the  2020 National Drug Threat Assessment report.

"Under current law, a Kentucky resident can only purchase up to a three months’ supply of the decongestant medication spread out over the course of a year, and they cannot purchase more than three packages at a single time," said a legislative news release. "HB 386 would eliminate these restrictions and replace them with a monthly limit."

The bill protects the original intent of the legislation, said Duvall. He said Kentucky will continue to be 20% more restrictive than the federal government's monthly purchase limits. 

"Kentucky has one of the strictest pseudoephedrine access laws in the country and will continue to do so," he said.

The bill would change the current 24-gram annual limit to an 86.4 grams, and remove the limit on the number of packages per transaction.

Duvall said these changes would bring Kentucky's law closer in line with the rest of the country, and explained why they are needed. 

"Under current law, an individual has access to just over three months' supply of over-the-counter medication per year. This means that individuals with chronic sinus congestion would have to ask their spouse or their other family members to purchase more pseudoephedrine for them after only three months," he said. "And for reference, the 7.2 gram per month maximum allows these allergy sufferers to take one pill every 24 hours to provide relief." 

He noted, "The current 24-gram annual limit is 78% less than what is typical for an American to purchase annually."

Duvall said the bill would not change the requirement to show a driver's license when purchasing the drug and the per-purchase limits will continue.

Duvall also pointed out that pseudoephedrine and phenylephrine are the two main oral decongestants in products available over the counter, but the U.S. Food and Drug Administration has concluded that phenylephrine in its oral form, as the main ingredient in many popular over-the-counter decongestants, doesn't thwart nasal congestion. 

If pseudoephedrine were pulled from the market, he said, "That would leave only one oral decongestant available over-the-counter." 

Saturday, February 10, 2024

Respiratory illness in Ky. keeps declining, but slowly, and is still elevated; more kids are in hospitals; not too late to get vaccinated

Ky. Department for Public Health graphs, adapted by Kentucky Health News
By Melissa Patrick
Kentucky Health News

While emergency-department visits and hospital admissions related to respiratory illness were again less numerous in the week ended Feb. 4, the state Department for Public Health still considers them elevated. 

ED visits for respiratory-associated illness in Kentucky in the week saw a 6.7% drop, to 3,005 visits, according to the health department's weekly respiratory report.

Kentucky hospital admissions for the diseases in Kentucky dropped 25% from the previous week, to 428 in the week ended Feb. 3. 

Admissions for all three respiratory viruses monitored by the state saw big drops. Flu admissions dropped 25%, to 222; Covid-19 admissions dropped 19.6%, to 168; and RSV admissions dropped 59%, to 28. 

Again, none of the state's counties had high rates of Covid-19 hospital admissions in the week ended Feb. 3, but 13 had admission rates between 10 and 19.9 admissions per 100,000 people, a rate the Centers for Disease Control and Prevention considers "medium."

The counties are bunched in Southern Kentucky (Barren, Hart, Metcalfe and Monroe), Central Kentucky (Boyle, Casey, Lincoln, Garrard and Mercer) and northeastern Kentucky (Elliott, Morgan, Menifee and Rowan). 

Children 4 and younger saw a slight uptick in hospital admissions for respiratory illness in the week ending Feb. 4, largely driven by nine Covid-19 admissions, eight more than the week prior. 

Children 5 to 17 saw a 40% increase in respiratory-related ED visits, to 737, and a 100% increase in hospital admissions (18), both driven by increases in flu. 

In the week ended Feb. 3, the state reported 3,415 laboratory-confirmed cases of the flu, less than a 1% decrease from the previous week It reported 2,173 lab-confirmed cases of Covid-19, up 4% from the week prior.

Since the first week in October, 296 Kentuckians have died from Covid-19, and 28 from the flu, the health department says. One Covid-19 victim and one flu victim were children. 

It's not too late to get vaccinated. Flu season in Kentucky runs through mid-May, RSV outbreaks tend to occur through the end of spring, and the CDC warns that the virus that causes Covid-19 is constantly changing and has not yet established a regular season. 

Health officials recommend that everyone 6 months old and older get the annual flu vaccine and updated Covid-19 vaccines, especially children younger than 5 or anyone at high risk for complications.

Vaccines for RSV are recommended for some infants and young children, pregnant women and adults 60 and older, although a shortage of the vaccine has been reported.

Earlier this week, WKYT-TV reported there have been six flu-related deaths in Lexington since October, and that the most recent deaths were a person in their 40s and another in their 60s. The health department told WKYT that 84% of the 2,030 people with lab-confirmed influenza in Fayette County since October had not received a seasonal flu shot.

Update 2/11/24: This story has been updated to reflect the correct number of children 4 and younger hospitalized for Covid-19 (nine) and the correct increase from the week prior (eight) when the state had only one Covid-19 hospitalization in this age group.  

Sunday, February 4, 2024

Respiratory viruses keep declining in Ky. but might be headed for plateau at 'elevated' level; flu up; updated Covid-19 vaccine works

Kentucky Department for Public Health graphs, adapted by Kentucky Health News
By Melissa Patrick
Kentucky Health News

Emergency-department visits and hospital admissions for respiratory-related illness in Kentucky have declined four weeks in a row, but the state health department still considers the state's rates of influenza, Covid-19 and respiratory syncytial virus to be elevated.

Health officials say the best way to protect yourself from these viruses is to stay up to date with your vaccines. 

The federal Centers for Disease Control and Prevention recommends that everyone 6 months old and older get the annual flu vaccine and updated Covid-19 vaccines, especially children younger than 5 or anyone at high risk for complications. 

Vaccines for respiratory syncitial virus (RSV) are recommended for some infants and young children, pregnant women and adults 60 and older, although a shortage of the vaccine has been reported. 

CDC graphic; for a larger version, click on it; to download, right-click.
A report published Feb. 1 in CDC's Morbidity and Mortality Weekly Report says early estimates show that people who have gotten the updated Covid-19 vaccine saw about 54% more protection against symptomatic Covid-19 infection than those who have not gotten the updated vaccination.

"Updated Covid-19 vaccines provide protection against symptomatic infection, including against currently circulating lineages," the report says.

The report shows the updated vaccine provides protection against the JN.1 strain of Covid-19, which became predominant in January of this year, and other circulating strains of the virus. 

Respiratory viruses in Kentucky

Emergency department visits for respiratory-associated illness in Kentucky in the week ended Jan. 27  stayed about the same as the week prior, dropping 3% from the week prior, to 3,187. But that was much less than the drops of around 20% seen in the previous three weeks, and flu cases showed show a slight uptick, indicating that respiratory virus activity may be headed for a plateau at elevated levels.

Respiratory-related hospital admissions in Kentucky dropped 5% from the week prior, when they declined 23%. And just like the emergency-department visits, flu was the only one of the three respiratory diseases tracked by the state to show a slight uptick.

Even with these declines, the state Department for Public Health says hospitalizations for respiratory illnesses remain high. 

CDC map, adapted by Kentucky Health News; click it to enlarge.
None of Kentucky's counties had high rates of Covid-19 hospital admissions in the week ended Jan. 27, but 21 of them had admission rates between 10 and 19.9 per 100,000 people, which the CDC considers a "medium" rate. Counties with a medium risk of Covid-19 hospitalization are in northeastern and western areas of the state. 

In the week ended Jan. 27, the state reported 3,377 laboratory-confirmed cases of the flu, up 2.5% from the week prior. It reported 1,994 laboratory-confirmed cases of Covid-19, down 3.6% from the week prior. 

Since the first week in October, 267 Kentuckians have died from Covid-19, and 28 have died from the flu, the health departnment says. One Covid-19 victim and one flu victim were children.

Sunday, January 28, 2024

Seasonal respiratory illness in Kentucky has declined for three weeks, but the numbers are still considered elevated

Ky. Dept. for Public Health graphs, adapted by Kentucky Health News
By Melissa Patrick
Kentucky Health News

Emergency-department visits and hospital admissions for respiratory disease in Kentucky have dropped for three weeks in a row, but the Kentucky Department for Public Health still considers the rate of respiratory virus activity to be elevated and the number of hospitalizations to be high. 

Respiratory illness-related ED visits have dropped 47% since the last week of 2023, when the health department showed the highest number of ED visits during this respiratory-illness season, 6,147. 

In the three weeks since, there has been a steady decline in such visits, dropping to 3,243 visits in the week ended Jan. 20.

Of those, 2,379 were for flu, down 15% from the week prior; 663 were for Covid-19, down 30% from the week prior; and 201 were for respiratory syncytial virus (RSV), down 38% from the week prior.

Hospital admissions associated with respiratory disease have also dropped steadily for three weeks in a row, to 530. That's down 47% from the season's high of 1,002 in the week ended Dec. 30. 

In the latest report, 236 admissions were for Covid-19, down 33% from the week prior; 216 were for flu, down 22% from the week prior; and 78 were for RSV, down 27% from the week prior.

Kentucky has no counties with high Covid-19 hospital admission rates in the week ended Jan. 20, according to the Centers for Disease Control and Prevention. However, it does have 24 counties with between 10 and 20 Covid-19 hospitalizations per 100,000 people, a rate the CDC considers "medium." These are largely in the easternmost part of the state and in a strip down the middle of the state. 

In the week ended Jan. 20, the state reported 2,042 laboratory-confirmed cases of Covid-19, down 32% from the prior week. It reported 2,745 lab-confirmed cases of the flu, down 16% from the week prior. 

Among children 4 and younger, the number of respiratory-illnessemergency-department visits also dropped for the last three weeks, to 697 in the week ended Jan. 20. That's down 53% from a season-high of 1,489 on Dec. 30. 

In the latest report, 471 vists of those 4 and younger were for flu, down 11% from the week prior; 125 were for RSV, down 33% from the prior week; and 101 were for Covid-19, down 30%.

Respiratory-related hospitalizations for children 4 and younger have dropped for six weeks in a row, down to 38 in the week ended Jan. 20 from a season-high of 134 in the week ended Dec. 16, a drop of 72%

In the latest report, 18 of the hospitalizations were for RSV, down 44% from the week prior; 12 were for flu, down 48% from the week prior;  and 8 were for Covid-19, 2 more than the week prior. 

Hospital visits also dropped among children 5 through 17, with 633 respiratory-related ED visits reported in the week ended Jan. 20, down 18% from the week prior. 

In the latest report, 565 of the yoith visits were for flu, a drop of nearly 19%; 54 were for Covid-19; and 14 were for RSV. The Covid-19 and RSV numbers have fluctuated little for several weeks.

The number of ED visits in this age group has declined from a high of 1,000 in the week ended Dec. 23, but it has not been a steady decline; there were nine hospitalizations in the week ended Jan. 20 among children aged 5-17, the same as the week before.

Of those, seven were for flu, up one from the prior week; one was for Covid-19, down from three the week prior; and one was for RSV, up from none the prior week. 

Since the first week in October, 236 Kentuckians have died from Covid-19 and eight have died from the flu. One of the Covid-19 deaths and one of the flu deaths have been children. 

In the week ended Jan. 6, there were two Covid-19 deaths and one flu death reported in Kentucky. These numbers follow two weeks where the state saw 23 Covid-19 deaths during each week.

Friday, January 12, 2024

State reports two Kentucky children have died, one from flu and one from Covid-19, but hospital visits show first decline in months

By Melissa Patrick
Kentucky Health News

As the state reported the first two deaths of children from Covid-19 and influenza, Kentucky saw the first drops in emergency-room visits and hospital admissions for the diseases in more than three months.

State health department graphs, adapted by Kentucky Health News
The weekly respiratory-illness update from the state Department for Public Health showed a 21% drop in emergency-department visits for the flu, Covid and respiritory syncitial virus (RSV), and a 13% drop in related hospitalizations the week ended Jan. 6. 

The children's deaths, one from Covid and one from flu, are the first pediatric deaths from respiratory illness reported this season. Neither child was vaccinated against the viruses that killed them, the department said. The report did not include any other information about the children. 

“Influenza and Covid-19 are serious illnesses that unfortunately can be deadly for some people, including young children,” said Dr. Steven Stack, the state's public health commissioner. “It is important for people who have not been vaccinated to get their updated influenza and Covid-19 vaccines this season, along with other recommended immunizations, to protect themselves.”

The Centers for Disease Control and Prevention recommends that everyone 6 months old and older get the annual flu and Covid vaccines, especially children younger than 5 or anyone at high risk for complications.

While hospital cases of the flu, Covid and RSV declined for the first time in many weeks, they continue to be widespread across Kentucky, says the release. 

Deaths are a lagging indicator of disease. Since Oct. 1, 165 Kentuckians have died from Covid-19 and seven have died from the flu, according to the health department's weekly respiratory report. 

In the week ended Jan. 6, Kentucky reported 3,173 laboratory confirmed cases of flu, down 19% from the week prior. The state reported 3,316 laboratory-confirmed cases of Covid, down nearly 14% from the prior week. 

Covid, the flu and RSV all saw a drop in emergency department visits and hospitalizations in the week ended Jan. 6. Flu has led in emergency-department visits for weeks, but Covid-19 has been the leading cause for hospitalizations since the state starting its reporting in October. 

Among children 4 and younger, the number of respiratory-related emergency-department visits and hospitalizations also dropped in the week ended Jan. 6. Emergency visits for this age group dropped 23% from the prior week, to 1,137, and hospitalizations dropped 18%, to 102. 

They also dropped among children 5-17, with 589 respiratory-related emergency department visits reported in the week ended Jan. 6, down nearly 40% from the prior week. However, respiratory-related hospitalizations in this age group increased to 19, up from 17 the week prior. 

A CDC report for the week ended Jan. 6 showed 11 Kentucky counties with hospitalization rates above 20 hospitalizations per 100,000 people, a rate the CDC considers high. 

Boyd, Carter, Greenup, Lawrence and Martin counties had a rate of 26.6 admissions per 100,000; Pike County had 22.9; Lewis County 21.8; and Daviess, Hancock, McLean and Ohio counties had 20.3.

Friday, January 5, 2024

Flu, up 33% in year's final week, continues to drive big jumps in respiratory illness in Kentucky; it's not too late to get a flu shot

Kentucky is in the CDC's third highest category of flu activity. (Chart adapted by Ky. Health News)
By Melissa Patrick
Kentucky Health News

Like the rest of the nation, Kentucky saw another big jump in influenza cases in the week ended Dec. 30, with visits to emergency departments for flu up 33% over the prior week and flu-related hospitalizations up nearly 48%.

"The influenza virus is the thing that's really skyrocketing right now," Dr. Steven Stack, Kentucky public-health commissioner and president of the Association of State and Territorial Health Officials, told NPR. "Influenza is sharply escalating and driving more hospitalizations."

The Centers for Disease Control and Prevention considers flu activity in Kentucky to be "very high." 

State health department graphs, adapted by Ky. Health News
The state's weekly report for the week ended Dec. 30 shows that the three respiratory that it tracks – flu, Covid-19 and respiratory syncytial virus – accounted for 5,662 vistis to Kentucky hospital emergency departments. That was an increase of 20% from the prior week, when the state recorded 4,703 such visits.  

For the third week in a row, flu cases accounted for a majority of the respiratory-illness cases seen by emergency departments. The latest report shows 3,802 of the visits were for flu, up from 2,854 in the prior week. 

Covid-19 cases increased 15% during the week, to 1,365, up from 1,183 the prior week. RSV cases dropped 25.6%, to 495 from 666 the prior week. 

Kentucky children four and younger saw an 8% increase in respiratory-related emergency-department visits, increasing to 1,378 from 1,271 the prior week. This increase was also driven by a 32% increase in flu cases, to 854, up from 646 the prior week. 

RSV cases among children under four dropped to 328 during the week, down from 453 the week prior, and 196 of the cases were for Covid-19, up from 172 the week prior. 

Kentucky children between the ages of 5 and 17 saw a slight drop in emergency department visits for respiratory illness, down to 928 from 994 the prior week.  Of those, 823 were for flu, down slightly from 861 the week prior; 75 for Covid-19, down from 77 the week prior; and 30 for RSV, down from 56 the week prior. 

The state considers all of these respiratory viruses to be at an elevated level, with hospitalizations for the flu increasing. 

Hospitalizations for respiratory illness increased to 857, up from 757 the week prior, an increase of 13%. Of those 404 were for Covid-19, up from 364 the week prior, an increase of nearly 11%; 306 were for flu, up from 207 the week prior, an increase of 47.8%; and 147 were for RSV, down from 186 the week prior, a decrease of nearly 21%.

Among children four an younger,  there were 122 hospitalizations related to respiratory illness, down slightly from 125 the week prior. Of those, 76 were for RSV, down from 97 the week prior; 28 were for flu, up from 16 the week prior, an increase of 75%; and 18 were for Covid-19, up from 12 the week prior. 

Among children 5-17, hospitalizations for respiratory illness dropped to 16, down from 25 the week prior. Of those, 13 were for flu, down from 19 the week prior; two were for RSV, down from five the week prior; and one was for Covid-19, the same as the week prior.

According to the CDC, 20 Kentucky counties had a high rate of Covid-19 hospitalizations in the week ended Dec. 30, with most of them in the far eastern and western parts of the state. Since last week's report, Clinton and Cumberland counites were added to this list. 

The CDC considers 20 or more hospitalizations per 100,000 people a high rate. 

Those counties were led by Pike, at 37.1 hospitalizations per 100,000 people; McCracken (23.6); Martin (20.2); Marshall (23.6); Magoffin (21.4); Lyon (23.6); Livingston (23.6); Lawrence (20.2); Johnson (21.4); Hickman (23.6); Greenup (20.2); Graves (23.6); Floyd (21.4); Cumberland (23.8); Crittenden (23.6); Clinton (23.8); Carter (20.2); Carlisle (23.6); Boyd (20.2); and Ballard (23.6). 

Since Oct. 7, Kentucky health officials have attributed 159 deaths to Covid-19, an average of about 12 per week. There have been seven flu-related deaths.

Doctors say the best way to prevent hospitalization for Covid-19, the flu and RSV is immunization. Vaccines are readily available for the flu and Covid-19. The RSV vaccines for infants and people over 60 are in shorter supply, so experts advise you to check with your doctor or nurse practitioner.

Stack "encourages seasonal preventive shots for everyone 6 months and older," NPR reports, but "says it's particularly important for 'everybody who is elderly — and not even old elderly — like young elderly, 60 and older,' since they are more likely to get very sick from these viruses." 

Experts say the best ways to not spread respiratory illness is to stay home if you are sick, to cover your coughs and sneezes with a tissue or your shirt sleeve, not your hands, and to keep your hands washed with soap and water.

Saturday, December 30, 2023

Rising flu cases drive continued increases in emergency-room visits and hospital admissions for respiratory illnesses in Kentucky

State graphs, adapted by Kentucky Health News
By Al Cross
Kentucky Health News

A big jump in influenza cases more than outweighed small declines in Covid-19 and respiratory syncitial virus as Kentuckians headed into the holidays, according to the state's latest respiratory-illness update.

The report for the week ended Dec. 23 shows the three illnesses accounted for 4,431 Kentucky emergency-department visits, an increase of 10.3 percent from the week before. That was driven entirely by a 30 percent increase in flu cases, from 2,109 to 2,737.

Covid-19 cases declined from 1,107 to 1,080 during the week, and RSV cases dropped from 802 to 614, a decline of 31 percent, accoridng to the report from the state Department for Public Health.

Kentucky hospital admissions for the three diseases rose only 3.3 percent, from 670 to 692, while admissions for the flu rose 36 percent, from 144 to 196.

Covid-19 admissions declined from 339 to 329, and RSV admissions declined from 187 to 167 during the week ended Dec. 23.

CDC map, adapted by Ky. Health News; click on any image to enlarge it.
The week saw the development of a new hotspot for Covid-19 hospital admissions, in far western Kentucky and two nearby Illinois counties. The rate of Covid-19 hospital admissions was 23.1 per 100,000 residents in Ballard, Carlisle, Hickman, Graves, Livingston, Lyon, McCracken and Marshall counties.

That list incudes all the counties in the Jackson Purchase except Calloway, which had a very low Covid-19 hospital-admission rate of 0.9 per 100,000, according to the Centers for Disease Control and Prevention, which considers rates above 20 to be high and below 10 to be low.

Parts of Kentucky's notheastern quadrant remained hotspots for Covid-19 hospital admissions. Greenup, Boyd, Carter and Martin counties had rates of 23.4 per 100,000. Pike County's rate was 20.3, and the rate in Fleming, Mason and Bracken counties was 20, according to the CDC.

Doctors say the best way to prevent hospitalization for Covid-19, the flu and RSV is immunization. Vaccines are readily available for the flu and Covid-19. The RSV vaccines for infants and people over 60 are in shorter supply, so experts advise you to check with your doctor or nurse practitioner.

Friday, December 22, 2023

CDC keeps urging health-care providers to recommend and offer vaccines; flu, Covid-19 and RSV rates are elevated in Kentucky

State Department for Public Health graphs, adapted by Ky. Health News
By Melissa Patrick
Kentucky Health News

The Centers for Disease Control and Prevention continues to encourage health-care providers to get their patients immunized against flu, Covid-19 and respiratory syncitial virus, noting that a recent poll shows that many Americans who have not yet been immunized report being open to vaccination.

"Strong provider recommendations for, and offers of, vaccination could increase influenza, Covid-19 and RSV vaccination coverage," says the CDC's Dec. 22 Morbidity and Mortality Weekly Report. 

The survey sample was drawn from a random-digit-dialed cellular telephone survey that included adults in every state.

It found that between Sept. 24 and Dec. 9, an estimated 40% of Kentucky adults reported they had gotten a flu shot; 15% had received an updated 2023-24 Covid-19 vaccine, and 23% of adults 60 and older had received a vaccine for RSV, which poses the greatest risk for seniors and infants. 

Kentucky's flu and updated Covid-19 vaccination rates are lower than the estimated national rates of 42% for flu and 18% for Covid-19, but higher than the national seniors rate for RSV, 17%. 

The state Department for Public Health's latest weekly respiratory-illness report shows that Covid-19, RSV and flu activity is elevated, and hospitalizations for RSV and flu are increasing. 

In the week ended Dec. 16, emergency-department visits for respiratory illness increased for yet another week, to 3,921, up from 3,670 the week prior. 

Of the latest week's cases, 2,072 were for flu, up from 1,720 the week prior; 1,073 were for Covid-19, down from 1,134; and 776 for RSV, down from 816. 

Among children 4 and younger, emergency-department visits due to respiratory illness increased slightly, to 1,303, up from 1,265 the week prior. Of those, 604 were for flu, up from 507; 570 were for RSV, down from 594; and 129 were for Covid-19, down from 164. 

Among children 5 to 17, emergency-department visits due to respiratory illness increased to 810, up from 653 the week before. Of those, 653 were for flu, up from 498. Covid-19 and RSV numbers stayed about the same as the week before, at 86 and 71, respectively. 

In that same week, hospital admissions for respiratory illness dropped a bit, to 617, down from 639 in the prior week. Of those, 310 were for Covid-19, down from 345; 171 were for RSV, down from 191; and 136 were for flu, up from 103. 

Among children 4 and under, hospitalizations for respiratory illness increased to 130, up from 105 the week prior. Of those, 101 were for RSV, up from 94; 19 were for flu, up from 7; and 10 were for Covid-19, up from 7. 

Among children 5 to 17, hospitalizations due to respiratory illness increased to 17, up from 10 the week prior. Of those, 13 were for flu, up from 4; 3 were for RSV, down from 4; and 1 was for Covid-19, the same as the week prior. 

A CDC report for the week ended Dec. 16 showed that Covid-19 hospitalization rates in 11 Kentucky counties were above 2 hospitalizations per 10,000 residents, which the CDC considers high. 

The leading county remains Letcher, with a rate of 2.3 hospitalizations per 100. The other high counties, with rates of 2.05 to 2.12, were all in northeastern Kentucky: Lewis, Greenup, Boyd, Carter, Rowan, Menifee, Morgan, Elliott, Lawrence and Martin. 

Deaths: Since Oct. 1, the state health department has attributed 118 deaths to Covid-19 and six to flu. One Covid-19 death was reported during the week ended Dec. 9.

Respiratory-related deaths for flu and Covid-19 on the state's weekly dashboard are reported according to when they occur, which sometimes leads to a delay between the actual date of death and the submission to the department.

Monday, December 18, 2023

Some decongestants spike blood pressure; alternatives available

Photo by September 15, iStock/Getty Images Plus
By Dr. Vincent Sorrell

It’s the season for respiratory viruses and the cough, congestion and sore throats they bring. There are many options for over-the-counter (OTC) remedies and relief, but if you have high blood pressure, you may want to take a closer look at the label. Some may contain warnings that advise against taking if you have high blood pressure. Others contain high levels of sodium, which can also increase blood pressure.

Some OTC decongestants contain pseudoephedrine, a drug that works by constricting the blood vessels to reduce nasal swelling. But with those blood vessels narrowed, blood pressure increases. For the 122 million Americans with hypertension, decongestants can raise an already elevated blood pressure to dangerous levels and increase the chance of heart attack and stroke.

Many OTC cold and flu medicines now have a version formulated specifically for those with high blood pressure. Allergy medicines can also relieve stuffy or runny noses without adverse side effects, just as cough medicines and expectorants to help clear mucus.

If you need relief from cold and sinus congestion without medication, try these at-home remedies:
  • Use a saline rinse to move saltwater through the nasal passages to clear out mucus.
  • Drink extra fluids to help thin the mucus.
  • Use a humidifier to moisten the air in your home and help clear your sinuses.
  • Get plenty of rest.
If your symptoms persist, and you’re concerned about which decongestant is the best for you, talk to your doctor.

Vincent Sorrell, M.D., is chief of cardiology at UK HealthCare’s Gill Heart & Vascular Institute.